Cadre Holdings Inc

Cadre Holdings Inc has a liquidity position that is medium in risk, with a current ratio of 3.17 and cash and equivalents of $105.9 million, but net cash is negative after subtracting total debt. The company's price-to-book ratio is 4.26, and its price-to-tangible-book ratio is also 4.26, indicating a premium valuation relative to its book value. The company's profitability is modest, with a return on equity of 4.2% and a return on assets of 2.02%. These figures are below the industry median for aerospace and defense firms, which typically exhibit higher returns due to the capital-intensive nature of the sector. The operating margin is 13.8%, and the net margin is 8.7%, both of which are in line with the industry average. Cadre Holdings Inc's revenue is concentrated in the aerospace and defense segment, with no disclosed geographic diversification. The company's primary market is the U.S. government, which accounts for a significant portion of its revenue. This concentration increases exposure to defense budget fluctuations and geopolitical shifts. The company's growth trajectory is modest, with a revenue of $144.3 million in the latest period. Analysts have set a mean price target of $45.00, suggesting a potential upside of 51.2% from the current market price of $29.78. The company's free cash flow is $11.6 million, and capital expenditures are -$3.4 million, indicating a net cash inflow from operations. The risk assessment for Cadre Holdings Inc indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio is 0.71, which is relatively low, but the negative net cash position after subtracting total debt is a concern. The company has not issued new shares recently, and there is no indication of dilution pressure in the near term. Recent events include the release of the latest financial data, which shows a net income of $12.6 million and an operating income of $19.95 million. The company has not disclosed any major new contracts or product launches in the recent filings. The analyst recommendations are mixed, with a mean recommendation of 2.17, indicating a slight buy bias, but no strong buy or hold ratings.